Kale Pratibha, Khillan Vikas, Sarin Shiv Kumar
a Department of Clinical Microbiology , Institute of Liver and Biliary Sciences , New Delhi , India.
b Department of Hepatology , Institute of Liver and Biliary Sciences , New Delhi , India.
Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1354-1357. doi: 10.1080/00365521.2018.1511826. Epub 2018 Oct 18.
Streptococcus gallolyticus subsp. gallolyticus bacteremia is associated with colorectal malignancies. There is limited data regarding the association of Streptococcus gallolyticus subsp. pasteurianus with malignancies. We aimed to study the pattern of isolation of Streptococcus gallolyticus and analysis of risk factors in patients with hepatobiliary diseases. We also planned to evaluate its association with hepatocellular malignancy.
We analyzed clinical and laboratory data of 68 cases of Streptococcus gallolyticus infections (77 isolates) from January 2013 to December 2017. These included blood (58), ascitic fluid (15), bile (2) and pleural fluid (2). We analyzed the risk factors in patients developing malignancy with Streptococcus gallolyticus infections.
Amongst the 68 patients studied, eight (11.76%) had confirmed malignancies, hepatocellular carcinoma (HCC) (5), rectal adenocarcinoma (1), pancreatic carcinoma (1) and uterine tumors (1). Simultaneous isolation of S. gallolyticus subsp. pasteurianus from blood and ascitic fluid in eight patients (11.8%, p = .01) was significantly associated with the occurrence of HCC. Streptococcus gallolyticus infection with HCC was associated with younger age (median 55 years), lymphocytosis and elevated gamma-glutamyl transferase (GGT).
This study provides a novel insight into the association of Streptococcus gallolyticus subspecies pasteurianus with HCC. The isolation of the organism from blood and ascitic fluid should prompt the clinicians to search for evidence of HCC actively.
解脲链球菌亚种溶脲亚种菌血症与结直肠癌相关。关于解脲链球菌亚种巴斯德亚种与恶性肿瘤的关联数据有限。我们旨在研究解脲链球菌的分离模式,并分析肝胆疾病患者的危险因素。我们还计划评估其与肝细胞恶性肿瘤的关联。
我们分析了2013年1月至2017年12月期间68例解脲链球菌感染(77株分离株)的临床和实验室数据。这些样本包括血液(58份)、腹水(15份)、胆汁(2份)和胸水(2份)。我们分析了发生解脲链球菌感染且患有恶性肿瘤的患者的危险因素。
在研究的68例患者中,8例(11.76%)确诊患有恶性肿瘤,其中肝细胞癌(HCC)(5例)、直肠腺癌(1例)、胰腺癌(1例)和子宫肿瘤(1例)。8例患者(11.8%,p = 0.01)血液和腹水中同时分离出巴斯德亚种解脲链球菌,这与HCC的发生显著相关。HCC合并解脲链球菌感染与较年轻的年龄(中位年龄55岁)、淋巴细胞增多和γ-谷氨酰转移酶(GGT)升高有关。
本研究为巴斯德亚种解脲链球菌与HCC的关联提供了新的见解。从血液和腹水中分离出该菌应促使临床医生积极寻找HCC的证据。